Stephen Hemsley

Executive spokesperson for UnitedHealth Group, delivering financial results and strategic outlook.

Claims

As speaker

Mentioned in

Key positions and views

UnitedHealth Group can achieve strong, double-digit earnings growth despite significant external pressures from government healthcare programs.

Sustained, large-scale investment in technology is a critical and non-negotiable component of future growth and efficiency.

The diversified Optum business is a key growth engine capable of offsetting challenges in the traditional insurance segments and maintaining stable long-term margins.

While facing discrete challenges like rising medical costs and membership shifts in the ACA marketplace, the overall business portfolio is robust enough to deliver strong results.

Increased operational transparency, such as publishing data on prior authorizations, is a necessary step for the company to take.

Podcast consensus on Hemsley

Points of consensus

▶UnitedHealth Group is positioned for strong earnings growth in 2026 and beyond, with projections of at least 8.6% growth for the year and a long-term target of 13% to 16%.Apr 2026

▶The Optum segments are a core component of the company's strategy, with stable long-term margin targets of 6% to 8% and a successful track record of offsetting membership losses in other areas.Apr 2026

▶Significant capital investment in technology is a key priority, with plans to invest nearly $1.5 billion in 2026 and a similar amount in 2027.Apr 2026

▶The company is taking steps toward greater transparency, committing to begin publishing performance data on prior authorizations and claim approval rates in 2026.Apr 2026

Points of debate

▶There is a significant tension between the company's optimistic earnings growth projections and the substantial financial headwinds identified, including $130 billion in Medicare Advantage funding reductions over three years and ongoing state Medicaid funding shortfalls.Apr 2026

▶A conflict exists between the projected double-digit earnings improvement at UnitedHealthcare and the simultaneous challenges of a commercial medical cost trend approaching 11% and a significant decline in commercial risk membership, particularly from the ACA exchange business.Apr 2026

▶The sustainability of Medicaid business margins is questionable, as the projected aggregate rate increases of 6% to 7% are explicitly stated to be below the expected medical cost trend for that segment.Apr 2026

▶The company's ability to manage its ACA exchange business is under pressure, with an expected margin of only around 1% (plus or minus 1%) and being the source of over 500,000 in expected membership decline.Apr 2026

Key themes

▶Confident Growth Projections Amidst HeadwindsApr 2026

Stephen Hemsley projects a strong financial future for UnitedHealth Group, forecasting adjusted EPS growth of at least 8.6% for 2026 and reaffirming a long-term growth target of 13-16%. This optimism is maintained despite explicitly acknowledging significant negative impacts from three consecutive years of Medicare funding reductions and shortfalls in state Medicaid programs.

Analysts should scrutinize the specific levers UNH plans to pull to bridge the gap between rising costs, government funding pressures, and its ambitious growth targets, as the current narrative presents a significant challenge to be overcome.

▶Strategic Importance and Realignment of OptumApr 2026

The Optum segments are presented as a key driver of performance and stability. Hemsley notes OptumRx's success in offsetting UnitedHealthcare membership losses and reaffirms the 6% to 8% long-term margin target for Optum. A strategic realignment is underway, moving Optum Financial Services into the Optum Insight segment.

The realignment of Optum Financial Services suggests a deeper integration of financial and data analytics capabilities, potentially creating new efficiencies or service offerings that could bolster Optum's margin goals.

▶Managing Rising Costs and Shifting MembershipApr 2026

Hemsley details several operational challenges, including a commercial medical cost trend approaching 11% and a notable decline in commercial risk membership, with over 500,000 attributed to the ACA exchange business. The Medicaid business also faces a margin squeeze, with rate increases lagging behind cost trends.

The high commercial cost trend is a critical variable for 2026 profitability; the company's ability to manage this through pricing, efficiency, or technology will be a key determinant of whether it meets its earnings goals.

▶Commitment to Technology and TransparencyApr 2026

A major strategic priority is the investment in technology, with a planned expenditure of nearly $1.5 billion in 2026 on 'modern intelligent technologies.' In parallel, Hemsley announced that the company will begin publishing performance data on prior authorizations and claim approval rates, signaling a move toward greater operational transparency.

The dual focus on tech investment and transparency may be a strategy to improve operational efficiency while also addressing public and regulatory scrutiny over insurer practices like prior authorization.

Source episodes

Sentiment over time

Not enough data for timeline

Changes over time

Full Year 2025

Reported full-year 2025 adjusted EPS of $16.35, slightly exceeding company expectations, though results included a $1.6 billion net of tax charge.

Q4 2025

Announced a strategic realignment to move the Optum Financial Services business into the Optum Insight segment.

2026 Outlook

Projected adjusted EPS to be greater than $17.75, representing at least 8.6% growth, despite anticipating negative impacts from Medicare and Medicaid funding issues.

2026

Plans to begin publishing performance data on prior authorizations and claim approval rates.

2026-2027

Commits to a significant technology investment cycle, planning to spend nearly $1.5 billion in each of these two years on modern intelligent technologies.

Long-Term

Reaffirmed leadership's belief that the company can achieve its long-term earnings growth rate target of 13% to 16%.

Suggested prompts

How does UnitedHealth Group plan to achieve its long-term 13-16% earnings growth target given the stated headwinds from Medicare and Medicaid funding reductions? &nearr;What specific 'modern intelligent technologies' is the company investing $1.5 billion in, and how are these expected to mitigate the commercial medical cost trend approaching 11%? &nearr;What are the strategic implications of realigning Optum Financial Services into Optum Insight, and how does this support the 6-8% long-term margin target for Optum? &nearr;Given the expected margin squeeze in the Medicaid business and membership losses in the ACA exchanges, what are the primary drivers for the projected double-digit earnings improvement at UnitedHealthcare in 2026? &nearr;

Key concepts

Earnings Projections & Guidance 5 ep Optum Strategy & Performance 4 ep UnitedHealthcare Segment 4 ep Government Program Funding (Medicare/Medicaid) 3 ep ACA Exchange Business 2 ep Medical Cost Trends 2 ep Technology Investment 1 ep Corporate Transparency 1 ep

Notable quotes

“We finished 2025 with adjusted earnings per share of $16.35, which was slightly ahead of our expectations.”

Stephen Hemsley · $UNH UnitedHealth Group Q4 2025 Earnings Conference Call

“Looking to 2026, we expect adjusted earnings per share of greater than $17.75 for growth of at least 8.6%.”

Stephen Hemsley · $UNH UnitedHealth Group Q4 2025 Earnings Conference Call

Report last updated: May 21, 2026

Get started free

Back to Entities Intelligence Report